Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14721808 | 0.89 | CYP1A2 (0.31) | LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL18677889 | 0.88 | — | — | |
| SCHEMBL14721258 | 0.85 | ALDH1A1 (0.36) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL18674474 | 0.84 | — | — | |
| SCHEMBL19529554 | 0.83 | PDK1 (0.41) | MEN1KMT2ATSHRPDK1PDK2 | |
| SCHEMBL17723712 | 0.81 | PDK1 (0.42) | MEN1KMT2ATSHRPDK1PDK2 | |
| SCHEMBL16097360 | 0.80 | PDK1 (0.42) | MEN1KMT2ATSHRPDK1PDK2 | |
| SCHEMBL14720719 | 0.76 | ALDH1A1 (0.39) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL18677961 | 0.75 | IDH1 (0.30) | — | |
| SCHEMBL18677926 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753674-B1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2016-02-10 | — | — | EP | disclosed |
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | DHR FINLAND OY (FI) | 2013-08-15 | — | — | US | disclosed |
| WO-2013026790-A9 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013026790-A1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | GLB1, SSB, LGALS3BP | MEN1 2313/4885KMT2A 4022/4885TSHR 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.